GenMark Diagnostics beats by $0.03, revenue in line


GenMark Diagnostics (GNMK): FQ3 EPS of -$0.24 beats by $0.03.

Revenue of $4.6M (-12% Y/Y) in line. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs